- Home
- SRPT vs MRK Comparison
SRPT vs MRK Comparison
Compare SRPT & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- MRK
- Stock Information
- Founded
- SRPT 1980
- MRK 2000
- Country
- SRPT United States
- MRK United States
- Employees
- SRPT N/A
- MRK N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- SRPT Health Care
- MRK Health Care
- Exchange
- SRPT Nasdaq
- MRK Nasdaq
- Market Cap
- SRPT N/A
- MRK 198.5B
- IPO Year
- SRPT 1997
- MRK N/A
- Fundamental
- Price
- SRPT $17.20
- MRK $79.11
- Analyst Decision
- SRPT Buy
- MRK Buy
- Analyst Count
- SRPT 25
- MRK 15
- Target Price
- SRPT $64.00
- MRK $113.71
- AVG Volume (30 Days)
- SRPT 7.5M
- MRK 17.5M
- Earning Date
- SRPT 08-06-2025
- MRK 07-29-2025
- Dividend Yield
- SRPT N/A
- MRK 4.09%
- EPS Growth
- SRPT N/A
- MRK 667.14
- EPS
- SRPT N/A
- MRK 6.88
- Revenue
- SRPT $2,233,371,000.00
- MRK $63,922,000,000.00
- Revenue This Year
- SRPT $26.87
- MRK $2.42
- Revenue Next Year
- SRPT $3.15
- MRK $5.77
- P/E Ratio
- SRPT N/A
- MRK $11.51
- Revenue Growth
- SRPT 59.15
- MRK 4.10
- 52 Week Low
- SRPT $16.96
- MRK $73.31
- 52 Week High
- SRPT $162.95
- MRK $129.93
- Technical
- Relative Strength Index (RSI)
- SRPT 18.61
- MRK 49.11
- Support Level
- SRPT $18.30
- MRK $78.14
- Resistance Level
- SRPT $22.98
- MRK $80.25
- Average True Range (ATR)
- SRPT 1.98
- MRK 1.77
- MACD
- SRPT -1.19
- MRK -0.05
- Stochastic Oscillator
- SRPT 0.89
- MRK 37.66
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.